Minimal clinically important difference for the 22‐item Sinonasal Outcome Test in medically managed patients with chronic rhinosinusitis
Clinical Otolaryngology2018Vol. 43(5), pp. 1328–1334
Citations Over TimeTop 10% of 2018 papers
Abstract
Based on our results, we propose a SNOT-22 MCID of 12 in medically managed patients with CRS. The MCID, while specific, was not sensitive for identifying patients with CRS experiencing a noticeable improvement in sinus symptoms or general health.
Related Papers
- → The Minimally Important Clinical Difference(2016)14 cited
- → Validation of the minimal clinically important difference for modified activities assessment scale(2021)5 cited
- → MINIMAL CLINICALLY IMPORTANT DIFFERENCE (MCID) OF THE DUTCH VERSION OF THE LEICESTER COUGH QUESTIONNAIRE AND BASELINE PREDICTORS OF REACHING THE MCID AFTER SIX MONTHS(2007)5 cited
- → Investigating the MCID of health status tools for patients with COPD in pulmonary rehabilitation(2014)
- → Minimal clinically important difference in Barthel dyspnoea after pulmonary rehabilitation in patients with Chronic Obstructive Pulmonary Disease(2020)